Natural Killer (NK) Cell Therapeutics Market Strategic Assessment & SWOT Analysis 2021-2028 | By Application, by Product | Key Players- Kiadis Pharma, Cytovia Therapeutics, Nkarta, Fate Therapeutics

Data Bridge Market Research has recently added a research report titled Natural Killer (NK) Cell Therapeutics market which provides a detailed picture of different industry facts of the Natural Killer (NK) Cell Therapeutics market. This professional and broad market report underlines the primary and secondary drivers, market share, possible sales volume, leading segments and geographical analysis. Global Natural Killer (NK) Cell Therapeutics market research report lends a hand for intelligent decision making and better manages marketing of goods and services which leads to growth in the business. Natural Killer (NK) Cell Therapeutics market report also contains all the major topics of the market research analysis that includes market definition, market segmentation, competitive analysis, major developments in the market, and excellent research methodology. Besides, businesses can utilize the information included in the market report to decide on their production and marketing strategies. It also provides a SWOT study to determine the companies’ pushing and restraining forces. This report is designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study. Key players in the market, major collaborations, merger and acquisitions along with trending innovation and business policies are also evaluated in this market during the forecast period 2027.

The natural killer (NK) cell therapeutics market is expected to gain market growth in the forecast period of 2021 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 40.5% in the forecast period of 2021 to 2027 and is expected to reach USD 1,006.39 million by 2027. Increase in usage of natural killer (NK) cell for the treatment of cancer and infectious diseases and rise in awareness about immunotherapies are the major drivers which propelled the demand of the market in the forecast period.

Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @

Major Market Players With An In-Depth Analysis:

  • Kiadis Pharma
  • Cytovia Therapeutics
  • Nkarta, Inc
  • Fate Therapeutics
  • EMERcell
  • Glycostem
  • Phio Pharmaceuticals, Innate Pharma, Inc
  • INmuneBIO
  • Gamida Cell
  • Bellicum Phamaceuticals, Inc
  • Acepodia Inc
  • Affimed GmbH
  • …………

Additional companies can be included on request

The report covers a detailed performance of some of the key players and analysis of major players in the industry, segments, application, and regions. Moreover, the report also considers the government’s policies in different regions which illustrates the key opportunities as well as challenges of the market in each region.

Segmentation: Natural Killer (NK) Cell Therapeutics Market

By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies)

By Application (Cancer, Acute Infectious Diseases, Immunoproliferative Disorders, Gastrointestinal Diseases, Others)

By End User (Hospitals, Specialty Clinics, Research & Academic Institutes)

Scope of the Report:

Global Natural Killer (NK) Cell Therapeutics market analysis report is a definitive solution for sound decision making and superior management of goods and services. This market report endows clients with the supreme level of market data and information which exactly matches to the niche and business requirements. The market research report delivers all-inclusive analysis of the market structure along with the estimations of the various segments and sub-segments of the market. Natural Killer (NK) Cell Therapeutics market report also analyzes the market status, market share, current trends, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors.

Valuable Points Covered in Natural Killer (NK) Cell Therapeutics Research Study are:

  • COVID-19 Impact Analysis & Post COVID-19 Revenue Opportunities on market
  • Strategically Natural Killer (NK) Cell Therapeutics Industry Insights and Growth – Relevancy Mapping
  • Market Forecast – Estimation & Approach
  • Interconnectivity & Related markets
  • Natural Killer (NK) Cell Therapeutics Market Ecosystem Map
  • Analysis of the evolution of Market segments, Market Competition Outlook & Key Statistics
  • Strategic Analysis for Cost Optimization
  • Natural Killer (NK) Cell Therapeutics Market Dynamics
  • Comprehensive SWOT analysis and unmatched research accuracy contribute to research reliability.
  • Product Development/Innovation & Investment Landscape
  • Company Competitive Intelligence

For More Insights Get FREE Detailed TOC @

Global Natural Killer (NK) Cell Therapeutics Market Scope and Market Size

On the basis of therapeutics, the natural killer (NK) cell therapeutics market is segmented into NK cell therapies and NK cell directed antibodies.

On the basis of approaches, the natural killer (NK) cell therapeutics market is segmented into antibody-dependent cell-mediated cytotoxicity (ADCC) and bispecific antibodies.

On the basis of application, the natural killer (NK) cell therapeutics market is segmented into cancer, acute infectious diseases, immunoproliferative disorders, gastrointestinal diseases and others.

On the basis of end user, the natural killer (NK) cell therapeutics market is segmented into hospitals, specialty clinics and research & academic institutes.

Competitive Landscape and Natural Killer (NK) Cell Therapeutics Market Share Analysis

The major companies which are dealing in the natural killer (NK) cell therapeutics are Kiadis Pharma, Cytovia Therapeutics, Nkarta, Inc., Fate Therapeutics, EMERcell, Glycostem, Phio Pharmaceuticals, Innate Pharma, Inc., INmuneBIO, Gamida Cell, Bellicum Phamaceuticals, Inc., Acepodia Inc., Affimed GmbH, multimmune GmbH, Bristol-Myers Squibb Company, Kleo Pharmaceuticals, iCell Gene Therapeutics, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., NantKwest and Merck KGaA among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For instance,

  • In July 2020, Kiadis Pharma had licensed its product pipeline K-NK004 to Sanofi. This product is indicated for treatment of multiple myeloma. This agreement helped the company to earn USD 20.67 million upfront which allowed it to boost up its drug development procedure.
  • In August 2020, Cytovia Therapeutics had filed a patent application for iPSC-Derived NK Cells in partnership with the New York Stem Cell Foundation (NYSCF) Research institute in order to produce the unlimited on demand NK and CAR- NK cell for treatment of cancer.

On the Basis of Region

The report is mainly segmented into several key regions, with sales, revenue, market share and growth rate of Natural Killer (NK) Cell Therapeutics in these regions, from 2021 to 2028, covering:

U.S., Canada and Mexico in North America, Germany, France, U.K.

Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe

China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand

Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA)

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample):

Also, Research Report Examines:

  • Competitive Analysis and manufacturers in global market
  • By Product Type, Applications & Growth Factors
  • Industry Trends and Outlook for Major Applications / End Users / Usage Area
  • Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Back to top button